{"id":1262,"date":"2020-10-01T00:00:00","date_gmt":"2020-10-01T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/10\/01\/september-2020-briefing-diabetes-endocrinology\/"},"modified":"2020-10-02T16:10:12","modified_gmt":"2020-10-02T16:10:12","slug":"september-2020-briefing-diabetes-endocrinology","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/10\/01\/september-2020-briefing-diabetes-endocrinology\/","title":{"rendered":"September 2020 Briefing &#8211; Diabetes &amp; Endocrinology"},"content":{"rendered":"<h3><\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>Here are what the editors at HealthDay consider to be the most important developments in Diabetes &#038; Endocrinology for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.<\/p>\n<p><font class=\"subhead\">Hospital Admissions Not Related to COVID-19 Fell in Early 2020<\/font><\/p>\n<p>WEDNESDAY, Sept. 30, 2020 (HealthDay News) &#8212; Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in <i>Health Affairs<\/i>.<\/p>\n<p><a href=\"https:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2020.00980\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Proton Pump Inhibitor Use Linked to Increased T2DM Risk<\/font><\/p>\n<p>TUESDAY, Sept. 29, 2020 (HealthDay News) &#8212; Regular use of proton pump inhibitors (PPIs) is associated with an increased risk for type 2 diabetes, according to a study published online Sept. 28 in <i>Gut<\/i>.<\/p>\n<p><a href=\"https:\/\/gut.bmj.com\/content\/early\/2020\/08\/29\/gutjnl-2020-322557\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Private Health Plans Pay Hospitals 247 Percent of Medicare<\/font><\/p>\n<p>MONDAY, Sept. 28, 2020 (HealthDay News) &#8212; During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.<\/p>\n<p><a href=\"https:\/\/www.rand.org\/pubs\/research_reports\/RR4394.html\" target=\"_new\" rel=\"noopener noreferrer\">More Information<\/a><\/p>\n<p><font class=\"subhead\">Exposure to Maternal Gestational Diabetes Tied to Higher CVD Risk<\/font><\/p>\n<p>MONDAY, Sept. 28, 2020 (HealthDay News) &#8212; Intrauterine exposure to maternal gestational diabetes is associated with an increased cardiovascular disease risk and risk factors in offspring up to age 35 years, according to a study published online Sept. 28 in <i>CMAJ<\/i>, the journal of the Canadian Medical Association.<\/p>\n<p><a href=\"https:\/\/www.cmaj.ca\/content\/192\/39\/E1104\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors<\/font><\/p>\n<p>THURSDAY, Sept. 24, 2020 (HealthDay News) &#8212; For individuals with type 2 diabetes, sodium glucose cotransporter 2 (SGLT2) inhibitors are associated with a reduced risk for cardiovascular events during short-term follow-up, according to a study published online Sept. 23 in <i>The BMJ<\/i>.<\/p>\n<p><a href=\"https:\/\/www.bmj.com\/content\/370\/bmj.m3342\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Measures of Central Adiposity Linked to All-Cause Mortality<\/font><\/p>\n<p>THURSDAY, Sept. 24, 2020 (HealthDay News) &#8212; Several indices of central adiposity, including waist circumference and body adiposity index, are associated with an increased risk for all-cause mortality, according to a review published online Sept. 23 in <i>The BMJ<\/i>.<\/p>\n<p><a href=\"https:\/\/www.bmj.com\/content\/370\/bmj.m3324\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Heavy Sugar-Sweetened Drink Intake Decreasing Overall in U.S.<\/font><\/p>\n<p>THURSDAY, Sept. 24, 2020 (HealthDay News) &#8212; Overall, heavy sugar-sweetened beverage (SSB) intake is declining among adults and children, according to a study published online Sept. 24 in the <i>Journal of the Academy of Nutrition and Dietetics<\/i>.<\/p>\n<p><a href=\"https:\/\/jandonline.org\/article\/S2212-2672(20)30902-3\/fulltext\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Metformin May Slow Cognitive Decline in Seniors With T2DM<\/font><\/p>\n<p>WEDNESDAY, Sept. 23, 2020 (HealthDay News) &#8212; For older adults with type 2 diabetes, cognitive decline is slower and dementia risk reduced for those receiving metformin, according to a study published online Sept. 23 in <i>Diabetes Care<\/i>.<\/p>\n<p><a href=\"https:\/\/care.diabetesjournals.org\/content\/early\/2020\/09\/14\/dc20-0892\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Oral Steroids May Raise Risks for Diabetes, HTN, VTE in Children<\/font><\/p>\n<p>WEDNESDAY, Sept. 23, 2020 (HealthDay News) &#8212; Children with current glucocorticoid exposure have increased risks for diabetes mellitus, hypertension, and venous thromboembolism (VTE), according to a study published online Sept. 9 in the <i>American Journal of Epidemiology<\/i>.<\/p>\n<p><a href=\"https:\/\/academic.oup.com\/aje\/advance-article-abstract\/doi\/10.1093\/aje\/kwaa197\/5902909\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Loneliness a Risk Factor for Type 2 Diabetes Mellitus<\/font><\/p>\n<p>TUESDAY, Sept. 22, 2020 (HealthDay News) &#8212; Loneliness is a risk factor for type 2 diabetes, according to a study published online Sept. 15 in <i>Diabetologia<\/i>.<\/p>\n<p><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00125-020-05258-6\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Glucocorticoids Linked to Hospitalized Infection Risk in RA<\/font><\/p>\n<p>TUESDAY, Sept. 22, 2020 (HealthDay News) &#8212; For patients with rheumatoid arthritis (RA) receiving disease-modifying antirheumatic drug (DMARD) therapy, continued use of glucocorticoids is associated with an increased risk for hospitalized infections, according to a study published online Sept. 22 in the <i>Annals of Internal Medicine<\/i>.<\/p>\n<p><a href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M20-1594\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M20-6010\" target=\"_new\" rel=\"noopener noreferrer\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Individuals With Autism at Risk for Other Health Conditions<\/font><\/p>\n<p>MONDAY, Sept. 21, 2020 (HealthDay News) &#8212; Individuals with autism have increased health risks even when considering lifestyle factors, according to a study published online Sept. 9 in <i>Autism<\/i>.<\/p>\n<p><a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/1362361320953652\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Cancer Incidence Up for Adolescents and Young Adults<\/font><\/p>\n<p>THURSDAY, Sept. 17, 2020 (HealthDay News) &#8212; Among adolescents and young adults (AYAs), cancer incidence increased during 2007 to 2016, according to a report published online Sept. 17 in <i>CA: A Cancer Journal for Clinicians<\/i>.<\/p>\n<p><a href=\"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full\/10.3322\/caac.21637\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Novel Risk, Protective Factors for Type 2 Diabetes Identified<\/font><\/p>\n<p>THURSDAY, Sept. 17, 2020 (HealthDay News) &#8212; Insomnia may be a risk factor for type 2 diabetes, according to a study published online Sept. 8 in <i>Diabetologia<\/i>.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1007\/s00125-020-05253-x\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Pacemaker Need Higher in Patients With Type 2 Diabetes<\/font><\/p>\n<p>WEDNESDAY, Sept. 16, 2020 (HealthDay News) &#8212; The need for pacemakers is higher among patients with type 2 diabetes than the general population, according to a study published online Sept. 4 in <i>Diabetes Care<\/i>.<\/p>\n<p><a href=\"https:\/\/care.diabetesjournals.org\/content\/early\/2020\/09\/02\/dc20-0084\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Handgrip Strength May Help Predict Risk for Type 2 Diabetes<\/font><\/p>\n<p>TUESDAY, Sept. 15, 2020 (HealthDay News) &#8212; Handgrip strength (HGS) is independently associated with the risk for type 2 diabetes, according to a study published online Sept. 3 in the <i>Annals of Medicine<\/i>.<\/p>\n<p><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2020.1815078\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Widespread Avoidance of Medical Care Found Due to COVID-19 Concerns<\/font><\/p>\n<p>THURSDAY, Sept. 10, 2020 (HealthDay News) &#8212; There was widespread reporting of avoidance of medical care due to COVID-19-related concerns in June 2020, according to research published in the Sept. 11 issue of the U.S. Centers for Disease Control and Prevention <i>Morbidity and Mortality Weekly Report<\/i>.<\/p>\n<p><a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6936a4.htm?s_cid=mm6936a4_w\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">CDC: Nearly 800 U.S. Children Have Developed COVID-19-Related Condition<\/font><\/p>\n<p>THURSDAY, Sept. 10, 2020 (HealthDay News) &#8212; There have been 792 confirmed cases in the United States of a rare condition in children that is linked to COVID-19, the U.S. Centers for Disease Control and Prevention said Wednesday.<\/p>\n<p><a href=\"https:\/\/www.cdc.gov\/mis-c\/cases\/index.html\" target=\"_new\" rel=\"noopener noreferrer\">More Information<\/a><\/p>\n<p><font class=\"subhead\">Moderate, Heavy Drinking Linked to Increased BP, HTN in T2DM<\/font><\/p>\n<p>THURSDAY, Sept. 10, 2020 (HealthDay News) &#8212; For individuals with type 2 diabetes, moderate and heavy drinking are associated with an increased risk for elevated blood pressure, stage 1 hypertension, and stage 2 hypertension, according to a study published online Sept. 9 in the <i>Journal of the American Heart Association<\/i>.<\/p>\n<p><a href=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.120.017334\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Poverty-Stricken Adults More Likely to be Calcium-, Vitamin D-Deficient<\/font><\/p>\n<p>THURSDAY, Sept. 10, 2020 (HealthDay News) &#8212; Adequate calcium and vitamin D intake in older Americans is greatly influenced by ethnicity, sex, household income, and food security, according to a study recently published in <i>PLOS ONE<\/i>.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0235042\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">High Coronary Artery Calcium + Diabetes Even Riskier for Women<\/font><\/p>\n<p>TUESDAY, Sept. 8, 2020 (HealthDay News) &#8212; For patients with diabetes, coronary artery calcium (CAC) predicts cardiovascular disease (CVD) and total mortality more strongly in women than men, according to a study published online Aug. 17 in <i>Diabetes Care<\/i>.<\/p>\n<p><a href=\"https:\/\/care.diabetesjournals.org\/content\/early\/2020\/08\/16\/dc20-0166\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Severe Hypoglycemia May Up Fall Risk in Older Adults With T2DM<\/font><\/p>\n<p>FRIDAY, Sept. 4, 2020 (HealthDay News) &#8212; Severe hypoglycemia is associated with a substantially higher risk for falls among community-dwelling adults with type 2 diabetes, according to a study published in the September issue of <i>Diabetes Care<\/i>.<\/p>\n<p><a href=\"https:\/\/care.diabetesjournals.org\/content\/43\/9\/2060\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Cardiovascular Health Tied to Lower Risk for Eye Diseases<\/font><\/p>\n<p>THURSDAY, Sept. 3, 2020 (HealthDay News) &#8212; Ideal cardiovascular health is associated with lower odds for ocular diseases, according to a study published Aug. 19 in <i>The American Journal of Medicine<\/i>.<\/p>\n<p><a href=\"https:\/\/www.amjmed.com\/article\/S0002-9343(20)30540-4\/fulltext\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Early Body Mass Index Tied to Cardiometabolic Risk at Age 11 to 12<\/font><\/p>\n<p>THURSDAY, Sept. 3, 2020 (HealthDay News) &#8212; Toddlers who are overweight or obese have higher cardiometabolic risk scores at 11 to 12 years of age, according to a study published in the Aug. 1 issue of <i>Pediatrics<\/i>.<\/p>\n<p><a href=\"https:\/\/pediatrics.aappublications.org\/content\/early\/2020\/07\/02\/peds.2019-3666\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Closed-Loop System Beneficial for Children With T1DM<\/font><\/p>\n<p>THURSDAY, Sept. 3, 2020 (HealthDay News) &#8212; For children with type 1 diabetes, a closed-loop system results in the glucose level being in the target range for more time than with use of a sensor-augmented insulin pump, according to a study published in the Aug. 27 issue of the <i>New England Journal of Medicine<\/i>.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2004736\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">High-Intensity Lifestyle Treatment Beneficial for Obesity in Underserved<\/font><\/p>\n<p>WEDNESDAY, Sept. 2, 2020 (HealthDay News) &#8212; For an underserved primary care population, a high-intensity lifestyle-based treatment program for obesity results in significant weight loss at 24 months, according to a study published in the Sept. 3 issue of the <i>New England Journal of Medicine<\/i>.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2007448\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe2025728\" target=\"_new\" rel=\"noopener noreferrer\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">Higher Vitamin D Levels Linked to Lower Risk for Type 2 Diabetes<\/font><\/p>\n<p>WEDNESDAY, Sept. 2, 2020 (HealthDay News) &#8212; Higher serum 25-hydroxyvitamin D (25OHD) concentrations are associated with a lower risk for incident type 2 diabetes (T2D), according to a study published online Aug. 26 in <i>Diabetes Care<\/i>.<\/p>\n<p><a href=\"https:\/\/care.diabetesjournals.org\/content\/early\/2020\/08\/25\/dc20-1109\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><font class=\"subhead\">No Link Between Hyperthyroidism Treatment, Solid Cancer Death<\/font><\/p>\n<p>WEDNESDAY, Sept. 2, 2020 (HealthDay News) &#8212; There is no association between treatment type for hyperthyroidism and later risk of solid cancer mortality, according to a study published online July 23 in <i>JAMA Network Open<\/i>.<\/p>\n<p><a href=\"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2768567\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">Neuropsychiatric Disorders Up in Offspring of Mothers With PCOS<\/font><\/p>\n<p>TUESDAY, Sept. 1, 2020 (HealthDay News) &#8212; Exposure to maternal polycystic ovary syndrome (PCOS) is associated with increased risk of a range of neurodevelopmental and psychiatric disorders in offspring, according to a study published online Aug. 31 in <i>Human Reproduction<\/i>.<\/p>\n<p><a href=\"https:\/\/academic.oup.com\/humrep\/advance-article\/doi\/10.1093\/humrep\/deaa192\/5899232\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><font class=\"subhead\">ADA Updates Guideline for Pharmacotherapy of T2DM<\/font><\/p>\n<p>TUESDAY, Sept. 1, 2020 (HealthDay News) &#8212; In a 2020 American Diabetes Association clinical guideline, published online Sept. 1 in the <i>Annals of Internal Medicine<\/i>, recommendations are presented for the pharmacologic treatment of adults with type 2 diabetes.<\/p>\n<p><a href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M20-2470\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.physiciansbriefing.com\/\" target=\"_new\" rel=\"noopener noreferrer\">ScoutNews, LLC<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Here are what the editors at HealthDay consider to be the most important developments in Diabetes &#038; Endocrinology for September 2020. This roundup includes the latest research news from journal &#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1262"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=1262"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1262\/revisions"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=1262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=1262"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=1262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}